A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

NCT04226989 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Non-Hodgkin's Lymphoma

Interventions

BIOLOGICAL: CT-RD06

Sponsor

He Huang

Collaborators

[object Object]